Ko Hanai

900 total citations
47 papers, 681 citations indexed

About

Ko Hanai is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Ko Hanai has authored 47 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Nephrology, 18 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Epidemiology. Recurrent topics in Ko Hanai's work include Chronic Kidney Disease and Diabetes (22 papers), Dialysis and Renal Disease Management (9 papers) and Diabetes Treatment and Management (9 papers). Ko Hanai is often cited by papers focused on Chronic Kidney Disease and Diabetes (22 papers), Dialysis and Renal Disease Management (9 papers) and Diabetes Treatment and Management (9 papers). Ko Hanai collaborates with scholars based in Japan, Australia and Ireland. Ko Hanai's co-authors include Tetsuya Babazono, Yasuko Uchigata, Yasuhiko Iwamoto, Kiwako Toya, Izumi Nyumura, Akiko Ishii, Ryotaro Bouchi, Nobue Tanaka, Mizuho Tanaka and Nobuaki Tanaka and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetologia.

In The Last Decade

Ko Hanai

43 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ko Hanai Japan 16 261 253 188 117 84 47 681
Elise Gand France 15 251 1.0× 226 0.9× 146 0.8× 90 0.8× 101 1.2× 35 675
Anne Sofie Astrup Denmark 14 228 0.9× 276 1.1× 333 1.8× 69 0.6× 121 1.4× 20 956
Jun Irita Japan 16 195 0.7× 141 0.6× 298 1.6× 77 0.7× 99 1.2× 32 746
Simone Theilade Denmark 17 167 0.6× 219 0.9× 446 2.4× 110 0.9× 185 2.2× 51 960
Taiga Hara Japan 16 233 0.9× 196 0.8× 140 0.7× 31 0.3× 103 1.2× 35 684
Nadja E.A. Drummen Netherlands 17 260 1.0× 144 0.6× 101 0.5× 62 0.5× 48 0.6× 21 1.0k
Giuseppe Palmiero Italy 14 231 0.9× 103 0.4× 358 1.9× 95 0.8× 172 2.0× 54 802
Steen Nielsen Denmark 12 177 0.7× 371 1.5× 191 1.0× 89 0.8× 82 1.0× 19 771
M.-A. Gall Denmark 11 342 1.3× 320 1.3× 374 2.0× 51 0.4× 98 1.2× 12 878
Galina Shenkerman Israel 10 139 0.5× 220 0.9× 100 0.5× 106 0.9× 35 0.4× 14 579

Countries citing papers authored by Ko Hanai

Since Specialization
Citations

This map shows the geographic impact of Ko Hanai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ko Hanai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ko Hanai more than expected).

Fields of papers citing papers by Ko Hanai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ko Hanai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ko Hanai. The network helps show where Ko Hanai may publish in the future.

Co-authorship network of co-authors of Ko Hanai

This figure shows the co-authorship network connecting the top 25 collaborators of Ko Hanai. A scholar is included among the top collaborators of Ko Hanai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ko Hanai. Ko Hanai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Babazono, Tetsuya, Ko Hanai, Yoichi Yokoyama, & Kazuhisa Uchiyama. (2023). Association between 1-year changes in urinary albumin-to-creatinine ratio and kidney disease progression in Japanese individuals with diabetes: a historical cohort study. Clinical and Experimental Nephrology. 27(12). 1001–1009. 4 indexed citations
4.
Sugawara, Yuka, Yosuke Hirakawa, Koki Mise, et al.. (2022). Analysis of Inflammatory Cytokines and Estimated Glomerular Filtration Rate Decline in Japanese Patients with Diabetic Kidney Disease: A Pilot Study. Biomarkers in Medicine. 16(10). 759–770.
5.
Yamamoto, Yui, et al.. (2021). Kidney outcomes and all-cause mortality in people with type 2 diabetes exhibiting non-albuminuric kidney insufficiency. Diabetologia. 65(1). 234–245. 15 indexed citations
6.
Tanaka, Nobue, et al.. (2019). Temporal trends in the prevalence of albuminuria and reduced eGFR in Japanese patients with type 2 diabetes. Diabetology International. 10(4). 279–287. 4 indexed citations
7.
Hanai, Ko, Tetsuya Babazono, & Yasuko Uchigata. (2016). Effects of statins on the kidneys in patients with type 2 diabetes. Clinical and Experimental Nephrology. 21(4). 633–642. 8 indexed citations
8.
9.
Babazono, Tetsuya, Noriko Yoshida, Kiwako Toya, et al.. (2014). A case of a type 2 diabetic patient with end-stage renal disease who experienced repeated pyrexia after hemodialysis due to acetate intolerance. Nihon Toseki Igakkai Zasshi. 47(11). 697–701. 1 indexed citations
10.
Bouchi, Ryotaro, Tetsuya Babazono, Izumi Nyumura, et al.. (2012). Non-linear association between ankle-brachial pressure index and prevalence of silent cerebral infarction in Japanese patients with type 2 diabetes. Atherosclerosis. 222(2). 490–494. 13 indexed citations
11.
Bouchi, Ryotaro, Tetsuya Babazono, Izumi Nyumura, et al.. (2011). Fluctuations in HbA1c are associated with a higher incidence of cardiovascular disease in Japanese patients with type 2 diabetes. Journal of Diabetes Investigation. 3(2). 148–155. 31 indexed citations
12.
Morita, Miwa, Yasuko Uchigata, Ko Hanai, Yohei Ogawa, & Yasuhiko Iwamoto. (2011). Association of Urinary Type IV Collagen With GFR Decline in Young Patients With Type 1 Diabetes. American Journal of Kidney Diseases. 58(6). 915–920. 29 indexed citations
13.
Hanai, Ko, Tetsuya Babazono, Naoko Yoshida, et al.. (2011). Gender differences in the association between HDL cholesterol and the progression of diabetic kidney disease in type 2 diabetic patients. Nephrology Dialysis Transplantation. 27(3). 1070–1075. 30 indexed citations
14.
Bouchi, Ryotaro, Tetsuya Babazono, Izumi Nyumura, et al.. (2010). Silent cerebral infarction is associated with the development and progression of nephropathy in patients with type 2 diabetes. Hypertension Research. 33(10). 1000–1003. 9 indexed citations
15.
Bouchi, Ryotaro, Tetsuya Babazono, Naoko Yoshida, et al.. (2010). Relationship between chronic kidney disease and silent cerebral infarction in patients with Type 2 diabetes. Diabetic Medicine. 27(5). 538–543. 16 indexed citations
16.
Hanai, Ko, Tetsuya Babazono, Izumi Nyumura, et al.. (2009). Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes. Nephrology Dialysis Transplantation. 24(6). 1884–1888. 80 indexed citations
17.
Bouchi, Ryotaro, Tetsuya Babazono, Izumi Nyumura, et al.. (2009). Is a reduced estimated glomerular filtration rate a risk factor for stroke in patients with type 2 diabetes?. Hypertension Research. 32(5). 381–386. 14 indexed citations
18.
Hanai, Ko, Tetsuya Babazono, Izumi Nyumura, et al.. (2009). Involvement of visceral fat in the pathogenesis of albuminuria in patients with type 2 diabetes with early stage of nephropathy. Clinical and Experimental Nephrology. 14(2). 132–136. 42 indexed citations
19.
Hanai, Ko, Tetsuya Babazono, & Yasuhiko Iwamoto. (2007). Renal manifestations of metabolic syndrome in type 2 diabetes. Diabetes Research and Clinical Practice. 79(2). 318–324. 17 indexed citations
20.
Babazono, Tetsuya, Ko Hanai, Koji Suzuki, et al.. (2006). Lower haemoglobin level and subsequent decline in kidney function in type 2 diabetic adults without clinical albuminuria. Diabetologia. 49(6). 1387–1393. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elise Gand Breakdown of academic impact, for papers by Anne Sofie Astrup Breakdown of academic impact, for papers by Jun Irita Breakdown of academic impact, for papers by Simone Theilade Breakdown of academic impact, for papers by Taiga Hara Breakdown of academic impact, for papers by Nadja E.A. Drummen Breakdown of academic impact, for papers by Giuseppe Palmiero Breakdown of academic impact, for papers by Steen Nielsen Breakdown of academic impact, for papers by M.-A. Gall Breakdown of academic impact, for papers by Galina Shenkerman
Rankless by CCL
2026